SGLT2 Inhibitors, Fish Oil in Hemodialysis, GLP-1 Drugs, and More—Highlights From Kidney Week

Jennifer Abbasi

doi:10.1001/jama.2025.21435

November 21, 2025JAMA

SGLT2 Inhibitors, Fish Oil in Hemodialysis, GLP-1 Drugs, and More—Highlights From Kidney Week

View at Publisher

Ask AI

Bookmark

Share

Key Points

The piece discusses key interventions and findings from Kidney Week related to nephrology treatments.
Interview with Katherine R. Tuttle, MD
Focus on recent advancements presented at Kidney Week 2025
Discussion of therapies including SGLT2 inhibitors and GLP-1 drugs.
Highlighting Hemodialysis treatment improvements
Overview of SGLT2 inhibitors and their role in kidney disease
Insights on Fish Oil usage in kidney health.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Medical News reports on Hemodialysis therapies and medications, indicating potential trends in nephrology treatment.

Abstract

This Medical News article is an interview with Katherine R. Tuttle, MD, education committee co-chair of Kidney Week 2025 and a professor of medicine at the University of Washington.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Jennifer Abbasi (2025) studied this question.

synapsesocial.com/papers/6924e405c0ce034ddc34f89a https://doi.org/10.1001/jama.2025.21435

View at Publisher

Ask AI

Bookmark

Share

SGLT2 Inhibitors, Fish Oil in Hemodialysis, GLP-1 Drugs, and More—Highlights From Kidney Week

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

SGLT2 Inhibitors, Fish Oil in Hemodialysis, GLP-1 Drugs, and More—Highlights From Kidney Week

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading